Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1983 Dec;42(3):955–964. doi: 10.1128/iai.42.3.955-964.1983

Immunity to herpes simplex virus type 2: recurrent lesions are associated with the induction of suppressor cells and soluble suppressor factors.

T Iwasaka, J F Sheridan, L Aurelian
PMCID: PMC264392  PMID: 6227561

Abstract

Cell-mediated immunity to herpes simplex virus type 2 was investigated in infected inbred strain 13/N guinea pigs with (45%), and without, a history of recurrent herpetic disease (A. D. Donnenberg, E. Chaikof, and L. Aurelian, Infect. Immun. 30:99-109, 1980). Induction of suppressor cells capable of reducing the proliferative response of herpes simplex virus type 2-stimulated immune lymphoid cells was demonstrated in spleen cells from animals with a history of recurrent disease at recrudescence and convalescence but not in spleen cells from quiescent animals or from animals without a history of recurrent herpetic disease (seropositive controls). Suppressor cells were also detected in the peripheral blood but only from three of seven studied animals, and only at recrudescence. In addition to inhibitory cell-cell interactions, the herpes simplex virus type 2-activated regulatory cells of animals with recrudescent herpetic lesions elaborated soluble suppressor factors affecting lymphocyte proliferation. Suppression mediated by suppressor factors was observed only when suppressor factors were added at an early stage of in vitro culture and was reversed by medium exchange throughout the 6 days of culture. Sephadex chromatography revealed the presence of factors capable of differentially modulating the proliferative response of herpes simplex virus-stimulated immune cells and concanavalin A-stimulated normal lymphoid cells.

Full text

PDF
955

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aston D. L., Cohen A., Spindler M. A. Herpesvirus hominis infection in patients with myeloproliferative and lymphoproliferative disorders. Br Med J. 1972 Nov 25;4(5838):462–465. doi: 10.1136/bmj.4.5838.462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bell R. B., Aurelian L., Cohen G. H. Proteins of herpes virus type 2 IV. Leukocyte inhibition responses to type common antigen(s) in cervix cancer and recurrent herpetic infections. Cell Immunol. 1978 Nov;41(1):86–102. doi: 10.1016/s0008-8749(78)80030-6. [DOI] [PubMed] [Google Scholar]
  3. Donnenberg A. D., Bell R. B., Aurelian L. Immunity to herpes simplex virus type 2 (HSV-2). I. Development of virus-specific lymphoproliferative and leukocyte migration inhibition factor responses in HSV-2-infected guinea pigs. Cell Immunol. 1980 Dec;56(2):526–539. doi: 10.1016/0008-8749(80)90127-6. [DOI] [PubMed] [Google Scholar]
  4. Donnenberg A. D., Chaikof E., Aurelian L. Immunity to herpes simplex virus type 2: cell-mediated immunity in latently infected guinea pigs. Infect Immun. 1980 Oct;30(1):99–109. doi: 10.1128/iai.30.1.99-109.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Douglas R. G., Jr, Couch R. B. A prospective study of chronic herpes simplex virus infection and recurrent herpes labialis in humans. J Immunol. 1970 Feb;104(2):289–295. [PubMed] [Google Scholar]
  6. Dutton R. W. Suppressor T cells. Transplant Rev. 1975;26:39–55. doi: 10.1111/j.1600-065x.1975.tb00174.x. [DOI] [PubMed] [Google Scholar]
  7. Ejercito P. M., Kieff E. D., Roizman B. Characterization of herpes simplex virus strains differing in their effects on social behaviour of infected cells. J Gen Virol. 1968 May;2(3):357–364. doi: 10.1099/0022-1317-2-3-357. [DOI] [PubMed] [Google Scholar]
  8. Ford W. L., Gowans J. L. The traffic of lymphocytes. Semin Hematol. 1969 Jan;6(1):67–83. [PubMed] [Google Scholar]
  9. Gershon R. K., Lance E. M., Kondo K. Immuno-regulatory role of spleen localizing thymocytes. J Immunol. 1974 Feb;112(2):546–554. [PubMed] [Google Scholar]
  10. Greene W. C., Fleisher T. A., Waldmann T. A. Soluble suppressor supernatants elaborated by concanavalin A-activated human mononuclear cells. I. Characterization of a soluble suppressor T cell proliferation. J Immunol. 1981 Mar;126(3):1185–1191. [PubMed] [Google Scholar]
  11. Jacobs R. P., Aurelian L., Cole G. A. Cell-mediated immune response to herpes simplex virus: type-specific lymphoproliferative responses in lymph nodes draining the site of primary infection. J Immunol. 1976 Jun;116(6):1520–1525. [PubMed] [Google Scholar]
  12. Kaufman D. B., Carnaud C., Stach J. L., Bach J. F. The suppressive effect of a supernate from concanavalin A-activated human lymphocytes: effects of concanavalin A-activated lymphocytes and their supernates on cytotoxic and mixed lymphocyte reactions. Cell Immunol. 1979 Sep 15;47(1):153–162. doi: 10.1016/0008-8749(79)90323-x. [DOI] [PubMed] [Google Scholar]
  13. Kaufman H. E., Brown D. C., Ellison E. D. Herpes virus in the lacrimal gland, conjunctiva and cornea of man--a chronic infection. Am J Ophthalmol. 1968 Jan;65(1):32–35. doi: 10.1016/0002-9394(68)91024-6. [DOI] [PubMed] [Google Scholar]
  14. Korsager B., Spencer E. S., Mordhorst C. H., Andersen H. K. Herpesvirus hominis infections in renal transplant recipients. Scand J Infect Dis. 1975;7(1):11–19. doi: 10.3109/inf.1975.7.issue-1.03. [DOI] [PubMed] [Google Scholar]
  15. Landy M., Baker P. J. Cytodynamics of the distinctive immune response produced in regional lymph nodes by Salmonella somatic polysaccharide. J Immunol. 1966 Nov;97(5):670–679. [PubMed] [Google Scholar]
  16. Lausch R. N., Swyers J. S., Kaufman H. E. Delayed hypersensitivity to herpes simplex virus in the guinea pig. J Immunol. 1966 Jun;96(6):981–987. [PubMed] [Google Scholar]
  17. Lomnitzer R., Rabson A. R. Mechanism of suppression of lymphocyte proliferation by Concanavalin A-activated mononuclear cells. Immunology. 1981 Jul;43(3):475–481. [PMC free article] [PubMed] [Google Scholar]
  18. Morahan P. S., Breinig M. C., McGeorge M. B. Immune responses to vaginal or systemic infection of BALB/c mice with herpes simplex virus type 2. J Immunol. 1977 Dec;119(6):2030–2036. [PubMed] [Google Scholar]
  19. Parker C. W., Dankner R. E., Falkenhein S. F., Greene W. C. Suggestive evidence for both stimulatory and inhibitory domains on human lymphocytes, as indicated by phospholipid turnover studies with wheat germ agglutinin and other lectins. Immunol Commun. 1976;5(1-2):13–25. doi: 10.3109/08820137609020609. [DOI] [PubMed] [Google Scholar]
  20. Rosenberg G. L., Farber P. A., Notkins A. L. In vitro stimulation of sensitized lymphocytes by herpes simplex virus and vaccinia virus. Proc Natl Acad Sci U S A. 1972 Mar;69(3):756–760. doi: 10.1073/pnas.69.3.756. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Scriba M. Herpes simplex virus infection in guinea pigs: an animal model for studying latent and recurrent herpes simplex virus infection. Infect Immun. 1975 Jul;12(1):162–165. doi: 10.1128/iai.12.1.162-165.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Sheridan J. F., Aurelian L. Immunity to herpes simplex virus type 2. V. Risk of recurrent disease following primary infection: modulation of T-cell subsets and lymphokine (LIF) production. Diagn Immunol. 1983;1(3):245–256. [PubMed] [Google Scholar]
  23. Sheridan J. F., Donnenberg A. D., Aurelian L., Elpern D. J. Immunity to herpes simplex virus type 2. IV. Impaired lymphokine production during recrudescence correlates with an imbalance in T lymphocyte subsets. J Immunol. 1982 Jul;129(1):326–331. [PubMed] [Google Scholar]
  24. Shou L., Schwartz S. A., Good R. A., Peng R., Chen C. L. A human soluble suppressor factor affecting lymphocyte responses in vitro. Proc Natl Acad Sci U S A. 1980 Oct;77(10):6096–6100. doi: 10.1073/pnas.77.10.6096. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Shou L., Schwartz S. A., Good R. A. Suppressor cell activity after concanavalin A treatment of lymphocytes from normal donors. J Exp Med. 1976 May 1;143(5):1100–1110. doi: 10.1084/jem.143.5.1100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Williams R. C., Jr, Korsmeyer S. J. Studies of human lymphocyte interactions with emphasis on soluble suppressor activity. Clin Immunol Immunopathol. 1978 Mar;9(3):335–349. doi: 10.1016/0090-1229(78)90105-8. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES